Literature DB >> 9819837

Design of HIV viral dynamics studies.

I C Marschner1.   

Abstract

HIV viral dynamics studies involve repeated measurement of viral load in HIV-infected individuals, to assess short-term rates of viral load change in response to interventions such as initiation or withdrawal of antiviral therapy. Such studies are an important source of information on HIV pathogenesis. This paper concerns some statistical issues arising in their design. Using a linear random-effects model to incorporate between-patient differences in rates of viral load change, I discuss the choice of number of individuals and frequency of observation per individual. I suggest an approach for calculating the optimal sample size and observation frequency, based on minimizing the total number of viral load measurements that one needs to undertake. The conclusion, using this approach, is that over a period of linear change in viral load, three to five measurements per individual is generally appropriate. I also examine the observation frequency when the number of available individuals is limited, in which case it is shown that one can use a higher frequency of measurement per individual to achieve adequate power or precision. Finally, I consider sources of data for prior specification of variance components, together with conservative designs that are insensitive to a lack of prior information about between-patient differences.

Entities:  

Mesh:

Year:  1998        PMID: 9819837     DOI: 10.1002/(sici)1097-0258(19981115)17:21<2421::aid-sim930>3.0.co;2-a

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Bayesian Experimental Design for Long-Term Longitudinal HIV Dynamic Studies.

Authors:  Yangxin Huang; Hulin Wu
Journal:  J Stat Plan Inference       Date:  2008-01-01       Impact factor: 1.111

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.